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Figure	7:	Galactose	and	NAG	exposure	on	platelet	surface	over	RT	and	cold	
long-term	storage.	Concentrated	PRP	was	procured	from	ACD-A	treated	WB	by	centrifugation	cell	fractionation	methods	and	stored	with	gentle	agitation	in	either	RT	(22	°C)	or	cold	(4	°C)	temperature	conditions.	Platelet	surface	GPIbα,	exposed	galactose	and	exposed	NAG	levels	were	monitored	2,	24,	72	and	120	hours	after	storage	in	respective	temperature	conditions.	Platelets	were	rewarmed	(37	°C)	for	15	minutes	before	analysis.	Red	lines	indicate	RT-stored	platelets	while	blue	lines	indicate	cold-stored	platelets.	Values	are	reported	as	mean	±	SEM,	n=3.	(A)	Schematic	of	the	GPIbα	with	notable	sugar	glycans;	sialic	acid,	galactose	and	NAG.	Sialic	acid	cleavage	is	mediated	by	NEU1	while	galactose	cleavage	is	mediated	by	Galactosidase,	together	leading	to	exposed	NAG.	This	phenomenon	is	implicated	as	being	cold-induced	and	mediating	cold-induced	platelet	clearance	(B)	GPIbα	is	significantly	cleaved	from	the	platelet	surface	over	time	in	both	RT	and	cold	stored	platelets	(two-way-ANOVA,	p	=	0.0335).	(C)	Total	platelet	surface	galactose	exposure	does	not	change	significantly	over	time	in	both	RT	and	cold	conditions,	with	no	significant	difference	between	RT	and	cold	stored	platelets	(D)	Total	platelet	surface	NAG	exposure	does	not	change	significantly	over	time	with	no	significant	difference	between	RT	and	cold	stored	platelets	(E)	Galactose	exposure	levels	normalized	to	GPIbα	have	observable	increase	over	time	with	no	significant	difference	between	RT	and	cold	stored	platelets.	(F)	NAG	exposure	levels	normalized	to	GPIbα	levels	have	observable	increase	over	time	with	no	significant	difference	between	RT	and	cold	stored	platelets.	
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Surface	A-GPIIbIIIa	and	surface	P-selectin	expression	of	RT	and	cold	stored	
platelets	Platelet	activation	induces	a	conformational	change	in	GPIIbIIIa,	transforming	the	receptor	from	its	unactivated	form	to	its	fibrin-adhesive-activated	form	(A-GPIIbIIIa).	Surface	A-GPIIbIIIa	presentation	on	the	platelet	surface	is	thus	a	biomarker	for	platelet	activation.	Upon	activation,	platelets	also	release	an	adhesion	receptor,	P-selectin,	from	their	alpha-granules	which	are	then	presented	on	the	cell	surface.	Surface	P-selectin	expression	can	thus,	also	serve	as	a	platelet	activation	biomarker.			In	an	effort	to	characterize	the	activation	status	and	hemostatic	functionality	of	long-term	RT	and	cold	stored	platelets	over	the	duration	of	their	storage,	surface	expression	of	platelet	activation	biomarkers,	P-selectin	and	A-GPIIbIIIa	were	monitored	at	select	time	points	(2,	24,	72	and	120	hours)	with	and	without	agonist	stimulation.	Specifically	both	the	percent	of	surface	A-GPIIbIIIa/P-selectin	positive	platelets	(%	gated)	and	mean	levels	of	surface	A-GPIIbIIIa/P-
Figure	8:	Surface	and	Total	NEU1	expression	of	platelets	under	RT	and	cold	
long-term	storage.	Concentrated	PRP	was	procured	from	ACD-A	treated	WB	by	centrifugation	cell	fractionation	methods	and	stored	with	gentle	agitation	in	either	RT	(22	°C)	or	cold	(4	°C)	temperature	conditions.	Surface	and	Total	(permeabilized	platelets)	NEU1	levels	of	platelets	in	each	condition	were	monitored	2,	24,	72	and	120	hours	after	storage	in	respective	conditions.	Platelets	were	rewarmed	(37	°C)	for	15	minutes	before	analysis.	Values	are	reported	as	mean	±	SEM,	n=3.	(A)	Percent	of	platelets	expressing	NEU1	does	not	significantly	differ	between	RT	and	cold	conditions	or	change	significantly	over	time.	(B)	Relative	levels	of	total	and	surface	NEU1	expression	do	not	significantly	differ	between	RT	and	cold-stored	platelet	or	change	significantly	over	the	course	of	storage.			
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selectin	per	A-GPIIbIIIa/P-selectin	positive	platelet	(MFI)	were	monitored.	Monitoring	surface	A-GPIIbIIIa/P-selectin	of	platelets	without	agonist	treatment	(HS	treated)	gives	insight	into	the	baseline	activation	status	of	the	platelet;	lower	percent	surface	A-GPIIbIIIa/P-selectin	positive	platelets	indicate	lower	baseline	activation	and	vise	versa.	The	relative	change	between	baseline	levels	of	surface	A-GPIIbIIIa/P-selectin	and	agonist-stimulated	levels	of	surface	A-GPIIbIIIa/P-selectin	give	insight	into	relative	platelet	reactivity;	a	larger	percent	positive	surface	A-GPIIbIIIa/P-selectin	fold	increase	between	baseline	and	agonist	stimulated	platelets	indicates	a	more	reactive	platelet	and	vise	versa.			
Surface	A-GPIIbIIIa	of	baseline	platelets	Percentage	of	surface	A-GPIIbIIIa	positive	platelets,	among	HS	treated	(baseline)	platelets,	did	not	statistically	change	over	the	course	of	either	RT	or	cold	storage	(Figure	9A).	Nor	was	the	percentage	of	surface	A-GPIIbIIIa	positive	platelets,	throughout	the	duration	of	storage,	significantly	different	between	RT	and	cold	stored	baseline	platelets	(Figure	9A).	Relatedly,	average	surface	A-GPIIbIIIa	levels	of	baseline	platelets	did	not	statistically	change	over	the	duration	of	storage	in	either	RT	or	cold	storage	conditions.	Nor	were	the	absolute	surface	A-GPIIbIIIa	levels,	throughout	the	duration	of	storage,	statistically	different	between	RT	and	cold	stored	baseline	platelets	(Figure	9B).			Together,	these	findings	suggest	the	baseline	activation	status	of	the	platelets	remain	largely	unchanged	over	the	duration	of	long-term	storage	in	either	RT	or	cold	conditions.	More	significantly,	these	findings	suggest	the	baseline	activation	statuses	of	platelets	are	not	significantly	different	between	RT	and	cold	stored	platelets.			
Surface	A-GPIIbIIIa	of	agonist	stimulated	platelets	Though	not	statistically	significant,	the	average	surface	GPIIbIIIa	positive	platelet	percent	fold	change	between	baseline	and	agonist	(ADP,	TRAP)	stimulated	RT	stored	platelets	had	an	observable	decline	over	the	duration	of	storage	(Figure	9C).	There	is	a	similar,	storage-time-dependent,	decline	in	the	surface	A-GPIIbIIIa	level	fold	increase	between	baseline	and	TRAP	stimulated	RT	platelets	
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(Figure	9D).	These	results	suggest	RT-stored	platelets	reactivity	toward	agonist	decreases	over	the	duration	of	storage.			Cold	stored	platelets	on	the	other	hand	don't	seem	to	exhibit	as	clear	a	storage-time-dependent	trend	and	have	a	fairly	static	average	surface	A-GPIIbIIIa	positive	percent	fold	change	over	the	duration	of	storage	(Figure	9C).	Interestingly,	cold-stored	platelets	seem	to	exhibit	an	ADP-stimulated	fold	increase	in	surface	A-GPIIbIIIa	levels	that	increases	with	longer	storage	time,	while	TRAP	stimulated	fold	increase	in	surface	A-GPIIbIIIa	level	is	largely	static	over	the	duration	of	storage	(Figure	9D).			These	results	demonstrate	cold	stored	platelets	generally	maintain	hemostatic	function	over	the	duration	of	storage.	Additionally	these	results	suggest,	of	the	cold-stored	platelets	that	do	react	to	agonist,	the	relative	level	of	their	activation	is	stronger	or	equally	strong	over	the	duration	of	storage.		It	is	also	worth	noting	that	the	average	surface	A-GPIIbIIIa	positive	percent	fold	change	is	observably	lower	in	cold-stored	platelets	compared	to	RT-stored	platelets	in	the	shorter	durations	of	storage	(2,	24	and	72	hours)	but	not	the	120	hour	long	storage	(Figure	9C).			Collectively,	these	results	suggest	cold-stored	platelets	better	maintain	hemostatic	function	over	the	duration	of	storage	as	compared	to	RT-stored	platelets,	which	decline	in	hemostatic	function	over	the	duration	of	storage.	Interestingly	however	RT-stored	platelets	demonstrate	more	robust	reactivity	to	agonist	in	the	earlier	stages	of	storage	than	cold-stored	platelets.		
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Surface	P-selectin	of	baseline	platelets	Percentage	of	surface	P-selectin	positive	platelets	among	baseline	RT	and	cold-stored	platelets	increased	significantly	(p<0.0001)	over	the	duration	of	storage	(Figure	10A).	The	average	surface	P-selectin	level	of	both	RT	and	cold	stored	baseline	platelets	also	significantly	increased	with	storage	time	(p=0.0245)	(Figure	10B).	The	percentage	of	surface	P-selectin	positive	platelets	was	not	statistically	different	between	RT	and	cold	stored	baseline	platelets.	Nor	was	the	
Figure	9:	Baseline	and	agonist	stimulated	activated	GPIIbIIIa	expression	
levels	of	platelets	under	RT	and	cold	long-term	storage.	Concentrated	PRP	was	procured	from	ACD-A	treated	WB	by	centrifugation	cell	fractionation	methods	and	stored	with	gentle	agitation	in	either	RT	(22	°C)	or	cold	(4	°C)	temperature	conditions.	Expression	of	activated	GPIIbIIIa	(A-GPIIbIIIa)	of	platelets	treated	with	HS	buffer	(control)	ADP	(20μM)	and	TRAP	(20μM)	were	monitored	2,	24,	72	and	120	hours	after	storage	in	respective	conditions.	Platelets	were	rewarmed	(37	°C)	for	15	minutes	before	analysis.	Values	are	reported	as	mean	±	SEM,	n=3.	(A)	Percent	of	A-GPIIbIIIa	positive	platelets	(B)	Average	levels	of	A-GPIIbIIIa	presentation	on	platelets	(C)	ADP	and	TRAP	stimulated	percent	fold	increase	in	A-GPIIbIIIa	positive	platelets	from	baseline	levels.	Dotted	line	indicates	1:1	fold	change	between	baseline	and	agonist-stimulated	A-GPIIbIIIa	positive	platelet	percent	(D)	ADP	and	TRAP	stimulated	fold	increase	in	levels	of	A-GPIIbIIIa	presentation	from	baseline	levels.	Dotted	line	indicates	1:1	fold	change	between	baseline	and	agonist-stimulated	A-GPIIbIIIa	presentation	level		
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mean	level	of	surface	P-selectin	statically	different	between	RT	and	cold	stored	baseline	platelets.			Though	not	statistically	significant,	worth	noting	is	the	observably	higher	percent	of	surface	P-selectin	positive	platelets	and	absolute	surface	P-selectin	levels	among	baseline	RT-stored	platelets	as	compared	to	baseline	cold-stored	platelets	at	the	120	hour	storage	mark	(Figure	10B).			Taken	together,	these	results	suggest	both	RT	and	cold	stored	platelets	have	storage-time-dependent	increasing	baseline	levels	of	activation.	In	other	words,	both	RT	and	cold	stored	platelets	seem	to	become	more	pre-activated	at	similar	rates	with	longer	storage	time.	Larger	baseline	activation	levels	of	RT	as	compared	to	cold	stored	platelets	by	120	hours	of	storage	might	suggest	RT	platelets	are	pre-activated	over	the	duration	of	storage	at	a	faster	rate	than	cold	platelets.			
Surface	P-selectin	of	agonist	stimulated	platelets		Surface	P-selectin	positive	percent	fold	change	between	baseline	and	ADP-stimulated	platelets	of	both	RT	and	cold	stored	platelets	are	insignificant	at	every	measured	time	point	(Figure	10C).	Similarly,	ADP-stimulated	surface	P-selectin	level	fold	increase	from	baseline	is	insignificant	in	both	RT	and	cold	stored	platelets	at	every	measured	time	point	(Figure	10D).	In	other	words,	platelets	of	both	temperature	conditions	appear	relatively	unresponsive	to	ADP	activation	in	the	context	of	surface	P-selectin	expression.		While	ADP	stimulation	has	little	impact,	TRAP	stimulation,	at	most	but	not	all	measured	time	points,	does	produce	an	observable	percent	fold	change	increase	in	surface	P-selectin	positive	platelets	in	both	RT	and	cold	stored	baseline	platelets	(Figure	10C).	The	exception	is	by	120	hours	of	storage	where	TRAP	stimulated	increase	in	surface	P-selectin	positive	platelets	is	small	in	both	RT	and	cold	stored	platelets	(Figure	10C).	Similarly,	TRAP	stimulation	also	increases	absolute	surface	P-selectin	levels	of	baseline	platelets	at	most	but	not	all	measured	time	points,	with	the	exception	being	by	120	hours	of	storage	again.	
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By	120	hours	of	storage	TRAP-stimulated	surface	P-selectin	level	fold	increase	is	very	weak	in	RT	stored	platelets	but	robust	in	cold	stored	platelets	(Figure	10D).			There	is	a	significant,	storage-time-dependent	decrease	(p<0.0001)	in	TRAP	stimulated	surface	P-selectin	positive	percent	fold	increase	in	both	RT	and	cold	stored	platelets	(Figure	10C).	However	it	is	worth	noting	the	observable	difference	in	the	rate	of	this	decline	between	cold	and	RT	stored	platelets.	The	rate	of	decline	in	TRAP	stimulated	surface	P-selectin	positive	percent	fold	increase	in	cold	stored	platelets	appears	to	be	slower	than	for	RT	stored	platelets.	This	trend	is	especially	apparent	if	we	note	that	cold	stored	platelets	show	lower	percent	fold	increase	in	surface	P-selectin	positive	platelets	at	all	but	the	last,	120-hour	storage	time	point,	where	percent	fold	increase	in	surface	P-selectin	is	comparable	between	cold	and	RT	stored	platelets.		There	is	also	a	significant,	storage-time-dependent	decrease	(p<0.1)	in	TRAP	stimulated	surface	P-selectin	level	fold	increase	in	both	cold	and	RT	stored	platelets	(Figure	10D).	There	is	also	an	observable	difference	in	the	rate	of	this	decline	in	TRAP	stimulated	surface	P-selectin	level	fold	increase	between	cold	and	RT	stored	platelets.		The	rate	of	decline	in	TRAP	stimulated	surface	P-selectin	level	fold	increase	in	cold	stored	platelets	appears	to	be	slower	than	for	RT	stored	platelets.	This	trend	is	especially	apparent	if	we	note	that	cold	stored	platelets	demonstrate	lower	TRAP	stimulated	surface	P-selectin	level	fold	increase	platelets	at	all	but	the	last,	120	hour	storage	time	point	where	surface	P-selectin	fold	increase	is	greater	for	cold	than	RT	stored	platelets.			These	results	collectively	suggest	there	is	a	storage-time-dependent	decrease	in	platelet	TRAP	stimulated	activation	in	both	RT	and	cold	stored	platelets.	There	is	also	the	suggestion	that	cold	stored	platelets	are	generally	less	reactive	than	RT	platelets	to	agonist	stimulation,	but	are	more	resistant	to	change	in	hemostatic	functionality	than	RT	stored	platelets,	leading	cold	stored	platelets	to	having,	by	the	end	of	the	storage	time	course,	similar	or	better	hemostatic	function	than	RT	platelets.		
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Figure	10:	Baseline	and	agonist	stimulated	P-selectin	expression	of	
platelets	under	RT	and	cold	long-term	storage.	Concentrated	PRP	was	procured	from	ACD-A	treated	WB	by	centrifugation	cell	fractionation	methods	and	stored	with	gentle	agitation	in	either	RT	(22	°C)	or	cold	(4	°C)	temperature	conditions.	Expression	P-selectin	of	platelets	treated	with	HS	buffer	(control)	ADP	(20μM)	and	TRAP	(20μM)	were	monitored	2,	24,	72	and	120	hours	after	storage	in	respective	conditions.	Platelets	were	rewarmed	(37	°C)	for	15	minutes	before	analysis.	Values	are	reported	as	mean	±	SEM,	n=3.	(A)	Percent	of	surface	P-selectin	positive	platelets.	Percent	of	surface	P-selectin	positive	platelets	among	baseline	RT	and	cold	stored	platelets	increased	significantly	over	the	duration	of	storage	(two-way-ANOVA,	p<0.0001)	(B)	Average	levels	of	surface	P-selectin	presentation	on	baseline	RT	and	cold	stored	platelets.	Average	surface	P-selectin	level	of	both	RT	and	cold	stored	baseline	platelets	significantly	increased	with	storage	time	(two-way-ANOVA,	p=0.0245)	(C)	ADP	and	TRAP	stimulated	percent	fold	increase	in	P-selectin	positive	platelets	from	baseline	levels.	Dotted	line	indicates	1:1	fold	change	between	baseline	and	agonist-stimulated	P-selectin	positive	platelet	percent.	TRAP	stimulated	surface	P-selectin	positive	percent	fold	increase	in	both	RT	and	cold	stored	platelets	declined	over	storage	duration	(two-way-ANOVA,	p<0.0001)	(D)	ADP	and	TRAP	stimulated	fold	increase	in	levels	of	P-selectin	presentation	from	baseline	levels.	Dotted	line	indicates	1:1	fold	change	between	baseline	and	agonist-stimulated	P-selectin	presentation	level.	TRAP	stimulated	surface	P-selectin	level	fold	increase	in	both	cold	and	RT	stored	platelets	declined	over	storage	duration	(two-way-ANOVA,	p=0.0382).		
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Annexin	V	positive	PDMP	and	Annexin	V	positive	procoagulant	surface	
production		Platelet	cell	membranes	have	an	asymmetric	distribution	of	different	types	of	phospholipids.	For	a	resting	platelet,	uncharged	phospholipids	such	as	phosphatidylcholine	and	sphingomyelin	mainly	comprise	the	outer	leaflet	of	the	membrane	bilayer	whereas	the	inner	leaflet	contains	negatively	charged	aminophospholipids	phosphatidylserine	(PS)	and	phosphatidylethanolamine	(PE).	During	platelet	activation,	this	distribution	becomes	disrupted	by	translocase	activity	and	aminophospholipids	are	flipped	to	the	extracellular	membrane	leaflet,	becoming	exposed	on	the	cell	surface.	Like	activated	platelets,	platelet	derived	microparticles	(PDMPs),	which	are	produced	by	activated	platelets,	similarly	present	these	aminophospholipids	on	their	surface.	Thus,	surface	aminophospolipid	expression	and	PDMP	production	can	be	biomarkers	for	platelet	activation.			Annexin	V	is	a	protein	that	binds	with	high	affinity	and	specificity	to	exposed	aminophospholipids	in	the	presence	of	Ca2+	ions.	We	are	thus	able	to	use	Annexin	V	and	forward	scatter	as	parameters	to	differentiate	between	aminophospholipid	expressing	platelets	and	PDMPs	by	flow	cytometric	analysis.			In	an	effort	to	better	elucidate	the	activation	status	and	reactivity	of	platelets	stored	long-term	in	RT	and	cold	temperature	conditions,	production	of	Annexin	V	positive	PDMPs	and	platelets	were	monitored.			Results	indicate	that	there	was	no	significant	difference	in	levels	of	Annexin	V	positive	PDMP	between	cold	stored	baseline	and	cold	stored	agonist-stimulated	platelets	at	any	time	points	(Figure	11A).	There	was	also	no	clear	storage	time	dependent	trend	in	the	levels	of	Annexin	V	positive	PDMP	produced	by	baseline	and	agonist	stimulated	cold-stored	platelets	(Figure	11A).		RT-stored	platelets	however	had	observable	increases	in	average	Annexin	V	positive	PDMP	concentrations	from	baseline	with	agonist	stimulation	(Figure	11A).	RT-stored	platelets	also	exhibited	an	observable	storage	time	dependent	decline	in	agonist-stimulated	Annexin	V	positive	PDMP	production	(Figure	11A).		
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	Together	these	results	suggest	RT-stored	platelets	respond	to	agonist	stimulation	and	produce	Annexin	V	positive	PDMP	whereas	cold-stored	platelets	have	high	baseline	levels	of	Annexin	V	positive	PDMP	and	do	not	respond	to	agonist	stimulation	to	produce	more	Annexin	V	positive	PDMP.	On	the	other	hand,	while	RT-stored	platelets	are	reactive	to	agonist	throughout	the	course	of	storage,	their	reactivity	observably	decreases	over	the	duration	of	storage.			Monitoring	of	Annexin	V	positive	platelets	revealed	that	with	agonist-stimulation,	both	RT	and	cold-stored	baseline	platelets	have	observable	increases	in	percent	Annexin	V	positive	platelets.	Results	indicate	the	agonist	stimulated	increase	in	percent	Annexin	V	positive	platelets	of	baseline	RT	platelets	significantly	decreases	over	the	duration	of	storage	(p<0.01)	(Figure	11B).	Cold-stored	platelets	however	do	not	have	a	clear	storage	time	dependent	trend	in	agonist	stimulated	percent	increase	in	Annexin	V	positive	platelets	(Figure	11B).	Together	these	results	might	suggest	cold-stored	platelets	are	less	subject	to	change	in	reactivity	while	RT-stored	platelets	decline	in	reactivity	with	longer	storage.			Also	worth	noting	is	the	difference	in	cold	and	RT	stored	baseline	percent	Annexin	V	positive	platelets.	Baseline	cold	stored	platelets	maintain	a	fairly	high	and	static	percent	Annexin	V	positive	platelet	values	throughout	the	duration	of	storage.	RT	stored	platelets	however	exhibit	an	increase	in	percent	Annexin	V	positive	platelets	over	the	duration	of	storage.	These	results	suggest	cold	stored	platelets	have	a	stable,	relatively	high	level	of	pre-activation	through	the	duration	of	storage	while	RT	stored	platelets	have	a	gradually	increasing	level	of	pre-activation	through	the	duration	of	storage.		
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Cold	stored	platelets	better	preserve	aggregate	formation	ability	as	
compared	to	RT	stored	platelets	Light	transmission	aggregometry	(LTA)	is	a	long-standing	reference	method	for	assessing	platelet	viability.	LTA	assesses	platelet	in	vitro	agonist	induced	activation	and	aggregate	formation	ability.	PRP	is	stirred	in	a	cuvette	placed	between	a	light	source	and	a	photocell	in	the	LTA	instrument.	A	PRP	solution	with	freely	suspended	platelets	is	homogenous	and	cloudy	and	impedes	light	transmission	through	solution.	Upon	the	addition	of	a	platelet	activating	agonist,	platelets	aggregate	allowing	for	the	larger	transmission	of	light	through	plasma	between	aggregates.	Thus	we	can	determine	the	percentage	of	maximal	aggregate	formation	by	the	relative	light	transmission	detected	(high	light	transmission	%	=	higher	%	aggregates).			
Figure	11:	Baseline	and	agonist	stimulated	Annexin	positive	PDMP	and	
platelets	of	RT	and	cold	stored	platelets.	Concentrated	PRP	was	procured	from	ACD-A	treated	WB	by	centrifugation	cell	fractionation	methods	and	stored	with	gentle	agitation	in	either	RT	(22	°C)	or	cold	(4	°C)	temperature	conditions.	Production	of	Annexin	V	positive	PDMP	and	Annexin	V	positive	platelets	with	CaCl2	(control)	and	Agonist	mix	(ADP	(20μM),	TRAP	(20μM),	convulxin	(0.2ng/mL),	CaCl2	(4.7mM))	treatment	was	monitored	2,	24,	72	and	120	hours	after	storage	in	respective	conditions.	Platelets	were	rewarmed	(37	°C)	for	15	minutes	before	analysis.	Values	are	reported	as	mean	±	SEM,	n=3.	(A)	Concentration	of	Annexin	V	positive	PDMP	in	baseline	(CaCl2)	and	stimulated	(Agonist	mix)	platelets.	(B)	Percent	of	Annexin	V	positive	platelets	of	all	platelet	and	PDMP	events	measured	in	baseline	(CaCl2)	and	stimulated	(Agonist	mix)	platelets.	Agonist	stimulated	increase	in	percent	Annexin	V	positive	platelets	of	baseline	RT	platelets	significantly	decrease	over	the	duration	of	storage	(two-way-ANOVA,	p=0.0016)	
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In	an	effort	to	elucidate	how	RT	and	cold-storage	might	influence	the	reactivity,	specifically	the	in	vitro	aggregate	formation	ability,	of	platelets,	LTA	was	performed	at	select	time	points	(2,	24,	72	and	120	hours).			Results	of	these	LTA	assays	demonstrate	that	RT-stored	platelets	on	average	exhibit	an	observable	decrease	in	aggregate	formation	in	response	to	agonist	(ADP	and	TRAP	especially)	with	longer	periods	of	storage	(Figure	12A,	B,	C).	Cold-stored	platelets	on	average	however	seem	to	retain	or	even	improve	ability	to	form	aggregates	in	response	to	agonists	over	the	duration	of	storage	(Figure	12A,	B,	C).	Statistically	however	only	aggregate	formation	in	response	to	ADP	was	significantly	different	(p<0.01)	between	RT	and	cold	stored	platelets.	Cold	stored	platelets	had	higher	%	aggregate	formation	(p<0.01)	than	RT	stored	platelets	in	response	to	ADP	with	longer	storage	(Figure	12A).			Collectively	these	LTA	results	suggest	cold-stored	platelets	better	retain	platelet	hemostatic	function,	specifically	ability	to	form	agonist	induced	(especially	ADP)	aggregates,	as	compared	to	RT-stored	platelets.		
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Figure	12:	Agonist	induced	
aggregate	formation	ability	of	
RT	and	cold-stored	platelets	
over	time.	Concentrated	PRP	was	procured	from	ACD-A	treated	WB	by	centrifugation	cell	fractionation	methods	and	stored	with	gentle	agitation	in	either	RT	(22	°C)	or	cold	(4	°C)	temperature	conditions.	ADP	(20μM),	Arachidonic	acid	(500μg/mL)	and	TRAP	(20μM)	induced	platelet	aggregate	formation	ability	was	assessed	2,	24,	72	and	120	hours	after	storage	in	respective	temperature	conditions	by	LTA.	Platelets	were	rewarmed	(37	°C)	for	15	minutes	before	analysis.	Red	lines	indicate	RT-stored	platelets	while	blue	lines	indicate	cold-stored	platelets.	Values	are	reported	as	mean	±	SEM,	n=3.	(A)	ADP	induced	%	platelet	aggregate	formation.	Aggregate	formation	in	response	to	ADP	was	significantly	different	between	RT	and	cold	stored	platelets	(two-way-ANOVA,	p=0.0079)	
(B)	AA	induced	%	platelet	aggregate	formation.	(C)	TRAP	induced	%	platelet	aggregate	formation.		
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DISCUSSION		Platelet	hemostatic	function	is	better	preserved	in	cold	rather	than	RT	conditions	over	long-term	storage.	The	rate	at	which	hemostatic	function	was	lost	over	the	duration	of	long-term	storage	was	observably	faster	for	RT	stored	platelets	as	compared	to	cold	stored	platelets.	This	conclusion	is	based	on	the	demonstration	that	percent	fold	increase	between	baseline	and	agonist	stimulated	platelets	in	activation	biomarker	positive	platelet	levels	and	average	activation	biomarker	levels	across	several	different	biomarkers	declined	more	rapidly	amongst	RT	stored	platelets	as	compared	to	cold	stored	platelets.	Specifically,	the	activation	biomarkers,	surface	A-GPIIbIIIa	and	P-selectin	demonstrated	these	trends.	The	following	evidence	demonstrated	in	this	study	supports	this	conclusion,	(1)	percent	fold	increase	in	both	surface	A-GPIIbIIIa	positive	platelets	and	average	surface	A-GPIIbIIIa	levels	between	baseline	and	agonist	stimulated	(ADP,	TRAP)	platelets,	was	static	or	increased	over	the	duration	of	cold	storage,	but	declined	over	the	duration	of	RT	storage,	and	(2)	percent	fold	increase	in	both	surface	P-selectin	positive	platelets	and	average	surface	P-selectin	levels	between	baseline	and	agonist	stimulated	(TRAP)	platelets,	declined	at	a	slower	rate	over	the	duration	of	cold	storage	as	compared	to	RT	storage.	Additionally	cold	stored	platelets	better	maintained	agonist	stimulated,	particularly	ADP	stimulated,	in	
vitro	aggregate	formation	ability	over	the	duration	of	storage	as	compared	to	RT	stored	platelets.	These	results	challenge	the	old	dogma	that	attribute	poor	viability	of	cold	stored	platelets	to	compromised	platelet	hemostatic	functionality	and	corroborate	the	growing	consensus	that	cold	storage	better	preserves	platelet	hemostatic	function	than	RT	storage.	Many	previous	studies	have	presented	similar	findings,	especially	regarding	cold	stored	platelets	having	better	aggregation	ability	than	RT	stored	platelets	in	response	to	ADP	stimulation	(Babic	et	al.,	2007;	Becker	et	al.,	1973;	Kattlove	et	al.,	1972;	Leytin	et	al.,	2004;	Reddoch	et	al.,	2014).			Effectively	these	results	demonstrate	the	advantage	of	storing	platelets	in	cold	temperature	over	RT	and	motivate	re-evaluation	of	current	RT	PC	storage	practice.			
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Interestingly,	in	this	study	RT	stored	platelets,	especially	at	earlier	time-points	of	storage,	exhibited	more	robust	activation	responses	in	the	form	of	activation	biomarker	(surface	A-GPIIbIIIa,	P-selectin,	Annexin	V	PDMP,	Annexin	V	platelets)	presentation	with	agonist	stimulation	than	cold	stored	platelets.	The	following	evidence	supports	this	finding	(1)	percent	fold	increase	in	surface	A-GPIIbIIIa	positive	platelets	between	baseline	and	agonist	stimulated	(ADP,	TRAP)	RT	stored	platelets	was	greater	than	that	of	cold	stored	platelets	at	earlier	storage	time	points	(2,	24,	72	hours),	(2)	percent	fold	increase	in	surface	P-selectin	positive	platelets	between	baseline	and	agonist	stimulated	(TRAP)	RT	stored	platelets	was	greater	than	that	of	cold	stored	platelets	at	earlier	time	points	(2,	24,	72	hours),	(3)	degree	of	agonist	stimulated	(ADP/TRAP/convulxin)	Annexin	V	positive	PDMP	production	was	higher	for	RT	stored	platelets	as	compared	to	cold	stored	platelets	and	(4)	degree	of	increase	in	percent	Annexin	V	positive	platelets	between	baseline	and	agonist	stimulated	(ADP/TRAP/convulxin)	RT	stored	platelets	was	higher	as	compared	to	cold	stored	platelets	at	earlier	time	points	(2,	24,	72	hours).	These	results	suggest	the	mechanisms	that	dictate	hemostatic	function	impairment	induced	by	RT	versus	cold	temperature	storage	is	kinetically	different.	We	might	speculate	that	hemostatic	function	impairment	in	cold	stored	platelets	is	initially	(within	the	first	two	hour	of	storage)	rapid	but	quickly	stabilizes	to	a	relatively	moderate	level	of	hemostatic	ability	whereas	hemostatic	function	impairment	in	RT	stored	platelets	is	gradual	and	continual	throughout	the	duration	of	storage.	Ultimately,	these	kinetic	differences	in	cold-induced	and	RT-induced	platelet	storage	lesions	might	suggest	mechanisms	underlying	these	phenomena	are	inherently	different.	RT-induced	platelet	storage	lesions	have	been	attributed	to	an	aging	process	inducing	progressive	loss	in	energy	generating	machinery.	In	contrast,	cold-induced	platelet	storage	lesions	have	been	speculated	as	being	attributed	to	biophysical	changes	such	as	membrane	rafting,	GPIba	clustering	and	cytoskeletal	rearrangement	(G.	White,	1972;	Gitz	et	al.,	2012;	Gousset	et	al.,	2004;	Hoffmeister	et	al.,	2003a;	Rumjantseva	et	al.,	2009;	White	and	Rao,	1998).	RT	and	cold	induced	platelet	storage	lesion	mechanisms	have	yet	to	be	fully	characterized	or	understood.			
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However,	results	of	this	study	also	suggest	by	120	hours	of	storage,	RT-stored	platelets	have	comparable	or	worse	hemostatic	function	than	cold	stored	platelets.	Specific	evidence	demonstrative	of	this	distinction	include	(1)	percent	fold	increase	in	average	surface	A-GPIIbIIIa	levels	between	baseline	and	agonist	stimulated	(ADP,	TRAP)	RT	stored	platelets	was	lower	as	compared	to	cold	stored	platelets	by	120	hours	of	storage	and	(2)	percent	increase	in	average	surface	P-selectin	levels	between	baseline	and	agonist	stimulated	(TRAP)	RT	stored	platelets	was	lower	compared	to	cold	stored	platelets	by	120	hours	of	storage.	The	demonstration	that	RT	stored	platelets	begin	with	better	but	end	with	worse	hemostatic	function	than	cold	stored	platelets	through	the	duration	of	storage	speaks	to	the	high	rate	with	which	RT	stored	platelets	lose	hemostatic	function	over	time	as	compared	to	cold	stored	platelets.	We	can	further	speculate	if	the	rate	of	decline	in	hemostatic	function	we	observe	for	RT	stored	platelets	was	maintained	with	longer	storage	time,	the	disparity	in	hemostatic	functionality	between	cold	and	RT	stored	platelets	would	increase	with	longer	storage	periods.	In	fact,	Babic	et	al.	demonstrates	that	beyond	14	days	of	RT-storage,	PC	platelets	lose	ability	to	aggregate	while	PC	platelets	stored	for	the	same	time	in	cold	temperature	retain	this	ability	(Babic	et	al.,	2007).	Hence	these	results	further	demonstrate	the	advantage	of	storing	platelets	in	cold	temperature	as	opposed	to	RT.			While	cold	storage	may	better	maintain	platelet	hemostatic	function,	the	problem	still	stands	that	cold	stored	platelets	are	susceptible	to	clearance	in	vivo	upon	transfusion.	The	proposed	mechanisms	behind	cold-induced	platelet	clearance	are	lectin	and	glycan	mediated	phagocytic	processes	carried	out	by	Kupffer	cells	and	hepatocytes.	In	an	effort	to	provide	more	insight	into	the	nature	of	long-term	cold	stored	platelet	clearance	mechanisms	particularly,	galactose	and	NAG	exposure	levels	on	surface	GPIbα	were	monitored	at	select	time	points	over	the	duration	of	long-term	(5	days)	storage.	The	results	of	this	time	course	reveal	increased	binding	of	ECL	and	sWGA	(normalized	to	surface	GPIbα	levels)	to	cold	stored	platelets	over	duration	of	storage,	suggesting	GPIbα	galactose	and	NAG	exposure	increases	with	longer	storage	duration.	This	is	in	line	with	results	of	previous	studies	demonstrating	galactose	exposure	levels	of	cold	stored	
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platelets	increases	over	a	48-hour	storage	period	(Rumjantseva	et	al.,	2009).	These	results	are	also	in	agreement	with	the	long-term	cold	storage	induced	platelet	clearance	mechanism	posed	by	Rumjantseva	et	al.;	increased	galactose	exposure	over	long-term	cold	storage	mediates	hepatocytic	phagocytosis.	Unexpectedly	however,	RT	stored	platelets	demonstrated	having	similar	increases	in	ECL	and	sWGA	binding	(normalized	to	surface	GPIbα	levels)	to	cold	stored	platelets,	suggesting	RT	and	cold	stored	platelets	have	comparable,	increasing	levels	of	GPIbα	galactose	and	NAG	exposure	over	the	duration	of	storage.	Previous	studies	have	demonstrated	relative	levels	of	platelet	surface	galactose	and	NAG	differ	between	short-term	RT	and	cold	stored	platelets	(≤2	hours)	(Hoffmeister	et	al.,	2003b)	but	none	to	my	knowledge	have	thus	far	compared	galactose/NAG	exposure	levels	of	long-term	(≥2	hours)	RT	and	cold	stored	platelets.	The	results	of	this	study	suggest	unlike	short-term	RT	and	cold	stored	platelets,	relative	levels	of	GPIbα	galactose	and	NAG	exposure	are	not	significantly	different	between	long-term	RT	and	cold	stored	platelets.	If	we	make	the	reasonable	assumption	that	RT	stored	platelets	of	this	study	do	not	rapidly	clear	from	circulation	as	cold	stored	platelets	do	(a	distinction	well	characterized	between	RT	and	cold	stored	platelets	in	previous	studies),	these	results	suggest	glycan	exposure	alone	cannot	predict	platelet	clearance	susceptibility.	Other	investigations	have	demonstrated	the	extent	of	galactose	exposure	on	the	surface	of	refrigerated	platelets	is	less	than	that	of	ST3GalIV+/-	platelets,	yet	ST3GalIV+/-	platelets	unlike	refrigerated	platelets	were	not	susceptible	to	rapid	clearance	and	retained	normal	circulation	lifetime	(Ellies	et	al.,	2002;	Grewal	et	al.,	2008).	Do	these	results	implicate	glycan	exposure	is	not	critical	to	cold-induced	platelet	clearance?	Not	necessarily.	These	results	may	suggest	it	is	the	interactive	effect	of	glycan	exposure	and	other	cold-induced	mechanisms	that	determine	platelet	clearance	susceptibility	of	cold	exposed	platelets.	For	example,	GPIbaα	clustering,	mediated	by	cold-induced	cytoskeletal	and	membrane	phase	change,	(Hoffmeister	et	al.,	2001)	could	be	responsible	for	enhancing	lectin	avidity,	which	may	crucially	determine	platelet	clearance	fate.	Hence	the	nature	of	glycan	re-composition	may	in	fact	be	similar	between	long-term	RT	and	cold	stored	platelets,	and	cold-induced	platelet	clearance	is	
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determined	by	the	interactive	effect	of	multiple	cold-induced	mechanisms	including	glycan	exposure.				The	results	of	this	study	suggest	NEU1	expression/production	does	not	change	significantly	over	the	duration	of	long-term	storage	nor	differ	significantly	between	RT	and	cold	stored	platelets	at	any	measured	time	point.	Previous	studies	have	demonstrated	surface	expression	of	NEU1	becomes	detectable	with	platelet	cold	storage,	suggesting	NEU1	is	responsible	for	cold-induced	desialylation	of	GPIbα	receptors	(Jansen	et	al.,	2012).	Although	not	explicitly	applied	to	the	cold-stored	platelet,	separate	studies	have	also	demonstrated	that	platelet	activation	via	GPIbα	induces	surface	presentation	of	NEU1,	leading	to	increased	desialylation	of	platelets	and	acute	thrombocytopenia	(Li	et	al.,	2015).	Reversal	of	these	NEU1	mediated	effects	with	the	application	of	dehydro-2-deoxy-N-acetylneuraminic	acid	(DANA),	a	neuraminidase	inhibitor,	were	also	further	demonstrated	(Li	et	al.,	2015).	Results	of	our	study	do	not	explicitly	discount	or	support	this	theory.	We	might	speculate	cold-induced	surface	expression	of	NEU1	happens	very	rapidly,	on	the	order	of	hours,	but	past	this	initial	translocation,	NEU1	surface	expression	level	and	production	remains	largely	static	for	the	remaining	duration	of	storage.	A	static	level	of	NEU1	surface	expression	does	not	compromise	the	possibility	that	NEU1	continues	actively	desialylating	platelet	glycans,	mediating	the	increasing	exposure	of	galactose	apparent	over	the	duration	of	long-term	storage.			In	future	I	hope	to	expand	the	sample	size	of	this	study	to	strengthen	my	statistical	analyses,	as	there	was	often	significant	within-group	variance	that	overwhelmed	between-group	variance.	Future	studies	would	additionally	benefit	with	the	inclusion	of	extra	time	points	for	experimental	analysis,	especially	earlier	in	the	course	of	storage	to	simultaneously	characterize	short-term	storage	effects	(0	hours	'fresh'	platelet	reference	especially).	Future	studies	would	also	benefit	with	the	use	of	apheresis	PC	products	instead	of	manually	procured	cPRP	used	in	this	study.	Apheresis	PCs	would	enable	procurement	of	larger	PC	volumes	from	a	single	donor,	which	would	more	practically	enable	analysis	at	more	storage	time	points,	eliminate	a	significant	amount	of	platelet	
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pre-activation	and	handling	attributed	to	the	manual	cell	fractionation	processes,	and	better	approximate	platelet	storage	standards.	Future	in	vivo	studies	that	complement	this	in	vitro	study	would	also	be	highly	beneficial.	For	example,	monitoring	platelet	clearance	rates	of	RT	and	cold	stored	platelets	in	in	vivo	mice	models	in	conjunction	with	this	study	would	better	inform	the	true	platelet	clearance	susceptibility	status	with	different	durations	and	temperature	conditions	of	storage.	Monitoring	bleeding	rates	of	mice	models	transfused	with	platelets	stored	in	RT	and	cold	conditions	for	different	durations	could	also	inform	the	validity	of	in	vitro	results	of	this	study.			
Concluding	remarks	Overall,	this	study	demonstrates	storing	platelets	in	cold	temperature	conditions	long-term	better	maintains	platelet	hemostatic	responsiveness	and	function	as	compared	to	storing	in	RT	conditions.	Such	findings	demonstrate	the	promise	of	refrigerating	platelets	for	use	in	transfusion	therapy	and	encourage	the	pursuit	for	a	means	of	protecting	cold	stored	platelets	from	in	vivo	clearance	for	optimal	application	in	transfusion	therapy.	Additionally,	this	study	demonstrates	platelet	GPIbα	galactose	and	NAG	exposure	is	comparable	between	long-term	RT	and	cold	stored	platelets.	This	is	contrary	to	previous	findings	demonstrating	greater	GPIbα	galactose	and	NAG	exposure	among	short-term	cold	stored	as	compared	to	RT	stored	platelets.	These	distinctions	in	glycan	exposure	between	short	and	long-term	stored	platelets	is	in	line	with	the	existence	of	a	second,	cold-induced,	glycan-integrin	mediated	platelet	clearance	mechanism	that	is	independent	of	a	short-term	cold	stored	platelet	clearance	mechanism	(Rumjantseva	et	al.,	2009;	Wandall	et	al.,	2008).												
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